Literature DB >> 15014902

A new model for separation between brain dopamine and serotonin transporters in 123I-beta-CIT SPECT measurements: normal values and sex and age dependence.

Erik Ryding1, Mats Lindström, Björn Brådvik, Martin Grabowski, Peter Bosson, Lil Träskman-Bendz, Ingmar Rosén.   

Abstract

123I-beta-CIT is a radioactive ligand for single-photon emission computed tomography (SPECT) imaging of the pre-synaptic (transporter) re-uptake sites for dopamine (DAT) and serotonin (5HTT), and it is widely used to visualize monoamine turnover. Since 123I-beta-CIT uptake occurs at 5HTT and DAT sites in conjunction with the presence of freely soluble 123I-beta-CIT in brain tissue, adequate separation of these three components is necessary. However, only partial separation is possible with current methods. Two main strategies have previously been used for 123I-beta-CIT component separation, based on the following considerations: (1) the faster uptake rate for 5HTT compared with DAT enables temporal separation by performing 5HTT imaging at 1-2 h and DAT imaging at 20-24 h; (2) blocking the 5HTT re-uptake with citalopram renders 123I-beta-CIT imaging DAT (non-5HTT) specific. In a new analytical model, we combined these two approaches with methods to isolate the passively dissolved 123I-beta-CIT in brain tissue from the monoamine transporter uptake, and to correct the 5HTT and DAT values for concomitant uptake. The new analytical model was used to study brain 5HTT and DAT in 23 normal subjects, with the aim of clarifying the effect of age and sex. A significant correlation between 5HTT and DAT values was found only in the thalamus, indicating successful component separation. Negative correlations between age and DAT were found for basal ganglia, thalami, brain stem and temporal lobes, but not for the frontal, parietal or occipital regions. No correlation with age was found for 5HTT. We found no sex difference for 5HTT or DAT.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15014902     DOI: 10.1007/s00259-004-1489-x

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  13 in total

1.  Effects of ageing on serotonin transporters in healthy females.

Authors:  J T Kuikka; L Tammela; K A Bergström; L Karhunen; M Uusitupa; J Tiihonen
Journal:  Eur J Nucl Med       Date:  2001-07

2.  Biodistribution and radiation dosimetry of [123I]ADAM in healthy human subjects: preliminary results.

Authors:  Tomi A Kauppinen; Kim A Bergström; Pertti Heikman; Jukka Hiltunen; Aapo K Ahonen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-11-09       Impact factor: 9.236

3.  Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging.

Authors:  W Pirker; S Asenbaum; M Hauk; S Kandlhofer; J Tauscher; M Willeit; A Neumeister; N Praschak-Rieder; P Angelberger; T Brücke
Journal:  J Nucl Med       Date:  2000-01       Impact factor: 10.057

4.  Striatal and extra-striatal D(2)/D(3) dopamine receptor occupancy by quetiapine in vivo. [(123)I]-epidepride single photon emission tomography(SPET) study.

Authors:  C M Stephenson; V Bigliani; H M Jones; R S Mulligan; P D Acton; D Visvikis; P J Ell; R W Kerwin; L S Pilowsky
Journal:  Br J Psychiatry       Date:  2000-11       Impact factor: 9.319

5.  beta-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivo.

Authors:  W Pirker; S Asenbaum; S Kasper; H Walter; P Angelberger; G Koch; A Pozzera; L Deecke; I Podreka; T Brücke
Journal:  J Neural Transm Gen Sect       Date:  1995

6.  Distribution of tracer levels of cocaine in the human brain as assessed with averaged [11C]cocaine images.

Authors:  F W Telang; N D Volkow; A Levy; J Logan; J S Fowler; C Felder; C Wong; G J Wang
Journal:  Synapse       Date:  1999-03-15       Impact factor: 2.562

7.  PET study of [11C]beta-CIT binding to monoamine transporters in the monkey and human brain.

Authors:  L Farde; C Halldin; L Müller; T Suhara; P Karlsson; H Hall
Journal:  Synapse       Date:  1994-02       Impact factor: 2.562

8.  Imaging of serotonin and dopamine transporters in the living human brain.

Authors:  J T Kuikka; J Tiihonen; K A Bergström; J Karhu; P Hartikainen; H Viinamäki; E Länsimies; J Lehtonen; P Hakola
Journal:  Eur J Nucl Med       Date:  1995-04

9.  Age-related decline in striatal dopamine transporter binding with iodine-123-beta-CITSPECT.

Authors:  C H van Dyck; J P Seibyl; R T Malison; M Laruelle; E Wallace; S S Zoghbi; Y Zea-Ponce; R M Baldwin; D S Charney; P B Hoffer
Journal:  J Nucl Med       Date:  1995-07       Impact factor: 10.057

10.  SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT. Binding kinetics in the human brain.

Authors:  T Brücke; J Kornhuber; P Angelberger; S Asenbaum; H Frassine; I Podreka
Journal:  J Neural Transm Gen Sect       Date:  1993
View more
  11 in total

1.  Automatic semi-quantification of [123I]FP-CIT SPECT scans in healthy volunteers using BasGan version 2: results from the ENC-DAT database.

Authors:  Flavio Nobili; Mehrdad Naseri; Fabrizio De Carli; Susan Asenbaum; Jan Booij; Jacques Darcourt; Peter Ell; Ozlem Kapucu; Paul Kemp; Claus Svarer; Claus Varer; Silvia Morbelli; Marco Pagani; Osama Sabri; Klaus Tatsch; Livia Tossici-Bolt; Terez Sera; Tierry Vander Borght; Koen Van Laere; Andrea Varrone
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-12-12       Impact factor: 9.236

2.  European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis.

Authors:  Andrea Varrone; John C Dickson; Livia Tossici-Bolt; Terez Sera; Susanne Asenbaum; Jan Booij; Ozlem L Kapucu; Andreas Kluge; Gitte M Knudsen; Pierre Malick Koulibaly; Flavio Nobili; Marco Pagani; Osama Sabri; Thierry Vander Borght; Koen Van Laere; Klaus Tatsch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-11-16       Impact factor: 9.236

3.  Topography of cerebral monoamine transporter availability in families with SCA2 mutations: a voxel-wise [123I]beta-CIT SPECT analysis.

Authors:  Christoph Scherfler; Sylvia M Boesch; Eveline Donnemiller; Klaus Seppi; Helga Weirich-Schwaiger; Georg Goebel; Irene Virgolini; Gregor K Wenning; Werner Poewe
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-05-13       Impact factor: 9.236

4.  Extrastriatal binding of [¹²³I]FP-CIT in the thalamus and pons: gender and age dependencies assessed in a European multicentre database of healthy controls.

Authors:  Walter Koch; Marcus Unterrainer; Guoming Xiong; Peter Bartenstein; Markus Diemling; Andrea Varrone; John C Dickson; Livia Tossici-Bolt; Terez Sera; Susanne Asenbaum; Jan Booij; Ozlem L Kapucu; Andreas Kluge; Morten Ziebell; Jacques Darcourt; Flavio Nobili; Marco Pagani; Swen Hesse; Thierry Vander Borght; Koen Van Laere; Klaus Tatsch; Christian la Fougère
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-05-08       Impact factor: 9.236

5.  Direct comparison of FP-CIT SPECT and F-DOPA PET in patients with Parkinson's disease and healthy controls.

Authors:  S A Eshuis; P L Jager; R P Maguire; S Jonkman; R A Dierckx; K L Leenders
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-11-27       Impact factor: 9.236

6.  Effect of sex on aging-related decline of dopamine transporter in healthy subjects.

Authors:  Seunghyeon Shin; Hyun-Yeol Nam; Myung Jun Lee; Kyoungjune Pak; Keunyoung Kim; In Joo Kim
Journal:  Ann Nucl Med       Date:  2020-10-14       Impact factor: 2.668

7.  Establishing On-Site Reference Values for (123)I-FP-CIT SPECT (DaTSCAN®) Using a Cohort of Individuals with Non-Degenerative Conditions.

Authors:  Nicolas Nicastro; Valentina Garibotto; Antoine Poncet; Simon Badoud; Pierre R Burkhard
Journal:  Mol Imaging Biol       Date:  2016-04       Impact factor: 3.488

8.  Single-site 123I-FP-CIT reference values from individuals with non-degenerative parkinsonism-comparison with values from healthy volunteers.

Authors:  Rachid Fahmi; Günther Platsch; Alexandre Bani Sadr; Sylvain Gouttard; Stephane Thobois; Sven Zuehlsdorff; Christian Scheiber
Journal:  Eur J Hybrid Imaging       Date:  2020-03-13

Review 9.  Dopamine Transporter Imaging, Current Status of a Potential Biomarker: A Comprehensive Review.

Authors:  Giovanni Palermo; Sara Giannoni; Gabriele Bellini; Gabriele Siciliano; Roberto Ceravolo
Journal:  Int J Mol Sci       Date:  2021-10-18       Impact factor: 5.923

10.  Neuromelanin-MRI to Quantify and Track Nigral Depigmentation in Parkinson's Disease: A Multicenter Longitudinal Study Using Template-Based Standardized Analysis.

Authors:  Yue Xing; Abdul Halim Sapuan; Antonio Martín-Bastida; Saadnah Naidu; Christopher Tench; Jonathan Evans; Gillian Sare; Stefan T Schwarz; Sarah Al-Bachari; Laura M Parkes; Sofia Kanavou; Jason Raw; Monty Silverdale; Nin Bajaj; Nicola Pavese; David Burn; Paola Piccini; Donald G Grosset; Dorothee P Auer
Journal:  Mov Disord       Date:  2022-02-15       Impact factor: 9.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.